Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of OSTENIL PLUS (Hyaluronic Acid) Versus SYNVISC-ONE in Patients With Tibiofemoral Osteoarthritis. A Randomised, Controlled, Double-blind, Parallel-group Study With a 6-month Follow-up

NCT03203408 is registered in ClinicalTrials.gov with TRB Chemedica as lead sponsor.

NCT NCT03203408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03203408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of OSTENIL PLUS (Hyaluronic Acid) Versus SYNVISC-ONE in Patients With Tibiofemoral Osteoarthritis. A Randomised, Controlled, Double-blind, Parallel-group Study With a 6-month Follow-up
Lead sponsor
TRB Chemedica
Phase
Not applicable
Overall status
Completed
Start date
June 21, 2011
Completion date
November 22, 2012
Enrollment
290 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis